Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation

Rapid repair of the denuded alveolar surface after injury is a key to survival. The respiratory tract contains several sources of endogenous adult stem cells residing within the basal layer of the upper airways, within or near pulmonary neuroendocrine cell rests, at the bronchoalveolar junction, and within the alveolar epithelial surface, which contribute to the repair of the airway wall. Bone marrow-derived adult mesenchymal stem cells circulating in blood are also involved in tracheal regeneration. However, an organism is frequently incapable of repairing serious damage and defects of the respiratory tract resulting from acute trauma, lung cancers, and chronic pulmonary and airway diseases. Therefore, replacement of the tracheal tissue should be urgently considered. The shortage of donor trachea remains a major obstacle in tracheal transplantation. However, implementation of tissue engineering and stem cell therapy-based approaches helps to successfully solve this problem. To date, huge progress has been achieved in tracheal bioengineering. Several sources of stem cells have been used for transplantation and airway reconstitution in animal models with experimentally induced tracheal defects. Most tracheal tissue engineering approaches use biodegradable three-dimensional scaffolds, which are important for neotracheal formation by promoting cell attachment, cell redifferentiation, and production of the extracellular matrix. The advances in tracheal bioengineering recently resulted in successful transplantation of the world's first bioengineered trachea. Current trends in tracheal transplantation include the use of autologous cells, development of bioactive cell-free scaffolds capable of supporting activation and differentiation of host stem cells on the site of injury, with a future perspective of using human native sites as micro-niche for potentiation of the human body's site-specific response by sequential adding, boosting, permissive, and recruitment impulses.

[1]  A. Harf,et al.  Transforming growth factor-beta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair? , 2006, American journal of physiology. Lung cellular and molecular physiology.

[2]  Thorsten Walles,et al.  Experimental generation of a tissue-engineered functional and vascularized trachea. , 2004, The Journal of thoracic and cardiovascular surgery.

[3]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[4]  G. Abatangelo,et al.  Functions of hyaluronan in wound repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  J. Dennis,et al.  Hyaluronan‐Based Scaffolds to Tissue‐Engineer Cartilage Implants for Laryngotracheal Reconstruction , 2007, The Laryngoscope.

[6]  Paolo Macchiarini,et al.  Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach , 2010, Journal of cellular and molecular medicine.

[7]  H. Jung,et al.  Prognosis of ramsay hunt syndrome presenting as cranial polyneuropathy , 2010, The Laryngoscope.

[8]  Claudio De Luca,et al.  Hyalograft® C: Hyaluronan-Based Scaffolds in Tissue-Engineered Cartilage , 2007, Cells Tissues Organs.

[9]  M. Rojas,et al.  Mesenchymal stem cells and inflammatory lung diseases. , 2009, Panminerva medica.

[10]  C. Pereira,et al.  Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.

[11]  M. Fishbein,et al.  Keratinocyte growth factor improves repair in the injured tracheal epithelium. , 2007, American journal of respiratory cell and molecular biology.

[12]  K. Omori,et al.  Regeneration of the Trachea Using a Bioengineered Scaffold with Adipose-Derived Stem Cells , 2008, The Annals of otology, rhinology, and laryngology.

[13]  J. Burdick,et al.  Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. , 2009, Tissue engineering. Part A.

[14]  B. Péault,et al.  Human airway xenograft models of epithelial cell regeneration , 2000, Respiratory research.

[15]  B. Stripp,et al.  Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. , 2002, The American journal of pathology.

[16]  Lingyun Sun,et al.  Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE , 2010, Nature Reviews Rheumatology.

[17]  Simon C Watkins,et al.  In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[18]  JC Snyder,et al.  Endogenous lung stem cells and contribution to disease , 2009, The Journal of pathology.

[19]  D. Calame,et al.  Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[21]  J. Thiery,et al.  Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage , 2005, Development.

[22]  B. Péault,et al.  Aquaporin‐3 Expression in Human Fetal Airway Epithelial Progenitor Cells , 2005, Stem cells.

[23]  M. Asashima,et al.  Ciliated Cells Differentiated from Mouse Embryonic Stem Cells , 2006, Stem cells.

[24]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[25]  Sara Mantero,et al.  Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.

[26]  A. Trounson,et al.  Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. , 2009, The American journal of pathology.

[27]  Junmin Zhu,et al.  Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. , 2010, Biomaterials.

[28]  J. Utikal,et al.  Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.

[29]  D. Warburton,et al.  VEGF-A signaling through Flk-1 is a critical facilitator of early embryonic lung epithelial to endothelial crosstalk and branching morphogenesis. , 2006, Developmental biology.

[30]  A. Caplan,et al.  Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. , 2010, Discovery medicine.

[31]  黄亚明 MedScape , 2009 .

[32]  Ludovic Vallier,et al.  Signaling Pathways Controlling Pluripotency and Early Cell Fate Decisions of Human Induced Pluripotent Stem Cells , 2009, Stem cells.

[33]  P. Macchiarini,et al.  Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. , 2010, The Journal of thoracic and cardiovascular surgery.

[34]  J. Dennis,et al.  Fabrication of a Neotrachea Using Engineered Cartilage , 2008, The Laryngoscope.

[35]  Fulin Chen,et al.  Novel strategy to engineer trachea cartilage graft with marrow mesenchymal stem cell macroaggregate and hydrolyzable scaffold. , 2010, Artificial organs.

[36]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[37]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[39]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[40]  D. Warburton,et al.  Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[41]  A. Keane-Myers,et al.  Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma , 2010, Proceedings of the National Academy of Sciences.

[42]  M. Arcasoy The non‐haematopoietic biological effects of erythropoietin , 2008, British journal of haematology.

[43]  J. Zahm,et al.  Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[44]  J. Whitsett,et al.  Sox17 Promotes Cell Cycle Progression and Inhibits TGF-β/Smad3 Signaling to Initiate Progenitor Cell Behavior in the Respiratory Epithelium , 2009, PloS one.

[45]  J. Hubbell,et al.  Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: Development and physicochemical characteristics. , 2005, Biomacromolecules.

[46]  J. Dorin,et al.  Following damage, the majority of bone marrow-derived airway cells express an epithelial marker , 2006, Respiratory research.

[47]  R. Hajj,et al.  Basal Cells of the Human Adult Airway Surface Epithelium Retain Transit‐Amplifying Cell Properties , 2007, Stem cells.

[48]  Kazuto Hoshi,et al.  An animal model study for tissue-engineered trachea fabricated from a biodegradable scaffold using chondrocytes to augment repair of tracheal stenosis. , 2008, Journal of pediatric surgery.

[49]  C. Lindsay Novel therapeutic strategies for acute lung injury induced by lung damaging agents: The potential role of growth factors as treatment options , 2011, Human & experimental toxicology.

[50]  Y. Chang,et al.  Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuate Hyperoxia-Induced Lung Injury in Neonatal Rats , 2009, Cell transplantation.

[51]  D. Amadori,et al.  Isolation of stem/progenitor cells from normal lung tissue of adult humans , 2009, Cell proliferation.

[52]  E. Mongodin,et al.  Differentiated and functional human airway epithelium regeneration in tracheal xenografts. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[53]  S. Randell,et al.  Evidence for stem-cell niches in the tracheal epithelium. , 2001, American journal of respiratory cell and molecular biology.

[54]  John Rollo,et al.  Biomaterials and scaffold design: key to tissue‐engineering cartilage , 2007, Biotechnology and applied biochemistry.

[55]  J. Zahm,et al.  Epithelial barrier integrity during in vitro wound repair of the airway epithelium. , 1996, American journal of respiratory cell and molecular biology.

[56]  O. Danos,et al.  Regeneration of a well‐differentiated human airway surface epithelium by spheroid and lentivirus vector‐transduced airway cells , 2004, The journal of gene medicine.

[57]  K. Omori,et al.  Regeneration of Tracheal Epithelium Utilizing a Novel Bipotential Collagen Scaffold , 2008, The Annals of otology, rhinology, and laryngology.

[58]  K. Hochedlinger,et al.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells , 2009, Nature Genetics.

[59]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[60]  S. Archer,et al.  Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. , 2009, American journal of respiratory and critical care medicine.

[61]  C. Gontan,et al.  Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. , 2008, Developmental biology.

[62]  D. Warburton,et al.  Stem/progenitor cells in lung development, injury repair, and regeneration. , 2008, Proceedings of the American Thoracic Society.

[63]  K. Weinberg,et al.  Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[64]  K. Omori,et al.  A tissue-engineered trachea derived from a framed collagen scaffold, gingival fibroblasts and adipose-derived stem cells. , 2010, Biomaterials.

[65]  K. Omori,et al.  Clinical Application of in Situ Tissue Engineering Using a Scaffolding Technique for Reconstruction of the Larynx and Trachea , 2008, The Annals of otology, rhinology, and laryngology.

[66]  Cheryl Miller,et al.  Developing a tissue‐engineered model of the human bronchiole , 2010, Journal of tissue engineering and regenerative medicine.

[67]  M. A. Princz,et al.  Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2) , 2008, Journal of biomaterials science. Polymer edition.

[68]  L. Byrnes,et al.  Mouse induced pluripotent stem cells. , 2008, The International journal of developmental biology.

[69]  B. Min,et al.  Tissue‐engineered allograft tracheal cartilage using fibrin/hyaluronan composite gel and its in vivo implantation , 2009, The Laryngoscope.

[70]  J. Dennis,et al.  Scaffold‐free tissue‐engineered cartilage implants for laryngotracheal reconstruction , 2010, The Laryngoscope.

[71]  K. Omori,et al.  Tissue Engineering for Regeneration of the Tracheal Epithelium , 2006, The Annals of otology, rhinology, and laryngology.

[72]  P. Flint,et al.  Coculture of mesenchymal stem cells and respiratory epithelial cells to engineer a human composite respiratory mucosa. , 2004, Tissue engineering.

[73]  Jae W. Lee,et al.  Potential application of mesenchymal stem cells in acute lung injury , 2009, Expert opinion on biological therapy.

[74]  J M Zahm,et al.  Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. , 1997, Cell motility and the cytoskeleton.

[75]  Tatsuo Nakamura,et al.  Regenerative Medicine of the Trachea: The First Human Case , 2005, The Annals of otology, rhinology, and laryngology.

[76]  M. Blasco,et al.  The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.

[77]  Tatsuo Nakamura,et al.  Experimental regeneration of canine larynx: a trial with tissue engineering techniques , 2007, Acta oto-laryngologica. Supplementum.

[78]  D. Warburton,et al.  Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages , 2008, Stem cells.

[79]  P. N. Rao,et al.  Circulating Progenitor Epithelial Cells Traffic via CXCR4/CXCL12 in Response to Airway Injury1 , 2006, The Journal of Immunology.

[80]  A. Bader,et al.  Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. , 2010, Rejuvenation research.

[81]  K. Matsushima,et al.  Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury , 2009, European Respiratory Journal.

[82]  B. Pitard,et al.  Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. , 2009, Human gene therapy.

[83]  Ana Jaklenec,et al.  Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. , 2008, Biomaterials.

[84]  D. Heinegård,et al.  The cartilage proteoglycan aggregate: assembly through combined protein-carbohydrate and protein-protein interactions. , 1994, Biophysical chemistry.

[85]  B. Stripp,et al.  Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. , 2001, American journal of respiratory cell and molecular biology.

[86]  Masayuki Yamato,et al.  Cell delivery in regenerative medicine: the cell sheet engineering approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[87]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.